Dabigatran etexilate (Pradaxa)

DRUG2 trials

Sponsors

University of Utah, Bayer

Conditions

Atrial FibrillationNon-valvular Atrial Fibrillation

Phase 4

Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation

TerminatedNCT01546883

University of UtahAtrial Fibrillation

Start: 2012-02-29End: 2013-12-31Updated: 2015-10-12

Unknown Phase

A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.

TerminatedNCT03715725

BayerNon-valvular Atrial Fibrillation

Start: 2018-10-31End: 2020-01-20Updated: 2020-12-10